Advanced search
Publication Cover
Substance Abuse Volume 36, 2015 - Issue 2: Expanding Treatment for Opioid Use Disorder: The Role of Pharmacotherapies
Journal homepage
247
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Buprenorphine Treatment for Probationers and Parolees

Michael S. GordonDepartment of Psychology, Friends Research Institute, Baltimore, Maryland, USA;Department of Criminal Justice, Stevenson University, Stevenson, Maryland, USACorrespondence[email protected]
, DPA,
Timothy W. KinlockDepartment of Psychology, Friends Research Institute, Baltimore, Maryland, USA;School of Criminal Justice, College of Public Affairs, University of Baltimore, Baltimore, Maryland, USA
, PhD,
Robert P. SchwartzDepartment of Psychology, Friends Research Institute, Baltimore, Maryland, USA
, MD,
Kathryn A. CouvillionDepartment of Psychology, Friends Research Institute, Baltimore, Maryland, USA
, BA,
Laura J. SudecDepartment of Psychology, Friends Research Institute, Baltimore, Maryland, USA
, BS,
Kevin E. O’GradyDepartment of Psychology, University of Maryland, College Park, College Park, Maryland, USA
, PhD,
Frank J. VocciDepartment of Psychology, Friends Research Institute, Baltimore, Maryland, USA
, PhD &
Hamin ShabazzDepartment of Criminal Justice, Stevenson University, Stevenson, Maryland, USA
, DPA show all
Pages 217-225 | Published online: 12 Mar 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Rachel K. Landis, Jonathan S. Levin, Brendan Saloner, Adam J. Gordon, Andrew W. Dick, Tisamarie B. Sherry, Douglas L. Leslie, Mark Sorbero & Bradley D. Stein. (2022) Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine. Substance Abuse 43:1, pages 1057-1071.
Read now
Robert P. Schwartz, Mary M. Mitchell, Kevin E. O’Grady, Sharon M. Kelly, Jan Gryczynski, Shannon Gwin Mitchell, Michael S. Gordon & Jerome H. Jaffe. (2018) Pharmacotherapy for opioid addiction in community corrections. International Review of Psychiatry 30:5, pages 117-135.
Read now
Daniel P. Riggins, Chinazo O. Cunningham, Yuming Ning & Aaron D. Fox. (2017) Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus–positive patients. Substance Abuse 38:3, pages 297-302.
Read now
Shannon Gwin Mitchell, Jennifer Willet, Laura B. Monico, Amy James, Danielle S. Rudes, Jill Viglioni, Robert P. Schwartz, Michael S. Gordon & Peter D. Friedmann. (2016) Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices. Substance Abuse 37:1, pages 127-133.
Read now

Articles from other publishers (9)

Danielle A. Ryan, Iván D. Montoya, Peter J. Koutoujian, Kashif Siddiqi, Edmond Hayes, Philip J. Jeng, Techna Cadet, Kathryn E. McCollister & Sean M. Murphy. (2023) Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities. Journal of Substance Use and Addiction Treatment 146, pages 208943.
Crossref
Irene Pericot-Valverde, Angelica Perez, Moonseong Heo, Ashley Coleman, Erik Ortiz, Krupa Merchant, Trish Melling & Alain Litwin. (2022) Rationale, design, and methodology of a randomized pilot trial of an integrated intervention combining computerized behavioral therapy and recovery coaching for people with opioid use disorder: The OVERCOME study. Contemporary Clinical Trials Communications 28, pages 100918.
Crossref
Rosemarie A. Martin, L.A.R. Stein, Damaris J. Rohsenow, Steven Belenko, Linda E. Hurley, Jennifer G. Clarke & Lauren Brinkley-Rubinstein. (2021) Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol. Journal of Substance Abuse Treatment 128, pages 108364.
Crossref
Sean M. Murphy, Philip J. Jeng, Sabrina A. Poole, Ali Jalali, Frank J. Vocci, Michael S. Gordon, George E. Woody & Daniel Polsky. (2020) Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials. Addiction Science & Clinical Practice 15:1.
Crossref
Daniel Winetsky, Aaron Fox, Ank Nijhawan & Josiah D. Rich. (2020) Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System. Infectious Disease Clinics of North America 34:3, pages 585-603.
Crossref
Peter D. Friedmann, Donna Wilson, Edward V. Nunes, Randall HoskinsonJrJr, Joshua D. Lee, Michael Gordon, Sean M. Murphy, Richard J. Bonnie, Donna T. Chen, Tamara Y. Boney & Charles P. O'Brien. (2018) Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?. Journal of Substance Abuse Treatment 85, pages 61-65.
Crossref
Sean M. Murphy, Daniel Polsky, Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, Edward V. Nunes, Richard J. Bonnie, Michael Gordon, Donna T. Chen, Tamara Y. Boney & Charles P. O'Brien. (2017) Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction 112:8, pages 1440-1450.
Crossref
Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, Edward V. Nunes, Tamara Y. Boney, Randall A. HoskinsonJr.Jr., Donna Wilson, Ryan McDonald, John Rotrosen, Marc N. Gourevitch, Michael Gordon, Marc Fishman, Donna T. Chen, Richard J. Bonnie, James W. Cornish, Sean M. Murphy & Charles P. O’Brien. (2016) Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. New England Journal of Medicine 374:13, pages 1232-1242.
Crossref
Michael S. Gordon, Timothy W. Kinlock, Frank J. Vocci, Terrence T. Fitzgerald, Asli Memisoglu & Bernard Silverman. (2015) A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners. Journal of Substance Abuse Treatment 59, pages 52-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.